Tag: ASX: OIL
Optiscan taps US manufacturer Long Grove Pharmaceuticals for surgical imaging partnership
Optiscan Imaging has entered a five-year collaboration with US drug manufacturer Long Grove Pharmaceuticals to jointly develop new clinical applications for the fluorescein sodium contrast agent used in surgical imaging.
Optiscan advances medical manufacturing with telepathology platform beta test
Optiscan Imaging has completed the beta phase for its cloud-connected telepathology platform, developed in partnership with Prolucid Technologies.
Featured Article
Don’t get left behind: Manufacturing’s urgent need for digital transformation
As digital transformation reshapes industries worldwide, manufacturers in Australia and beyond are finding themselves at the forefront of an evolution. This shift presents opportunities for companies looking to improve efficiency, drive innovation, and boost growth.
